How do I contact Mark Chin?

Mark Chin, Managing Director at Arix Bioscience, can be reached by email. The verified email address is listed on this page.

What is Mark Chin's email address?

Mark Chin's email address uses the arixbioscience.com domain (shown as *****@arixbioscience.com until revealed).

What does Mark Chin invest in?

Mark Chin backs Health tech companies at Series A and Seed, typically writing €92k–€4.6M cheques.

How do I cold email Mark Chin?

Mark Chin backs Health tech companies at Series A and Seed, writing €92k–€4.6M cheques. A concise cold email that leads with relevant traction and one specific ask, sent to the verified address on this page, is the most direct way to reach Mark.

Where is Mark Chin based?

Mark Chin is based in New York City, United States and works at Arix Bioscience.

Mark Chin Email & Contact Information

Managing Director @ Arix Bioscience

Show Mark's email

Mark Chin Location

New York City, United States

Mark Chin Investing

Managing Director at Arix Bioscience

Stages: Series A, Seed
Sectors: Health tech
Cheque size: €92k–€4.6M
Freshness: Verified 1mo ago

Mark Chin Summary

Mark Chin, based in New York City, United States, is a Managing Director at Arix Bioscience. Mark Chin invests in Health tech at Series A and Seed, writing €92k–€4.6M cheques. Mark Chin's verified email and contact details are available on Mintround.

How to cold email Mark Chin

Mark Chin, Arix Bioscience in New York City, United States, backs Health tech companies at Series A and Seed, writing €92k–€4.6M cheques. Here's how to get a reply when you cold email Mark:

Subject line: name your company and one metric that matters to Health tech, not “quick chat”.
First line: your strongest traction, the real numbers, not adjectives.
One ask: a 20-minute call with a date range. Keep it under 150 words.
Send it to Mark's verified address below. No warm intro required.

Show Mark's email

Notable investments

Ottimo PharmaSeries A · $140M · 2024
VicebioSeries B · $100M · 2024
EvommuneSeries B · $50M · 2023
EnsomaSeries B · $85M · 2023
Disc MedicinePost Ipo Equity · $54M · 2022
VelosBioSeries B · $140M · 2020
ImaraSeries B · $63M · 2019
Harpoon TherapeuticsSeries C · $70M · 2018

Frequently co-invests with

Joseph AndersonSoffinova Partners2×Ash KhannaPivotal bioVenture PartnersDavid BonitaOrbiMedDerek DiRoccoRA CapitalKevin BittermanAtlas VentureKouki HarasakiM12 - Microsoft's Venture FundKush Parmar5am VenturesLuke EvninMPM CapitalMona AshiyaOrbiMed AdvisorsPeter ThompsonOrbiMedRob HopfnerPivotal bioVenture PartnersStephen KnightF-Prime Capital Partners

Mark Chin's colleagues at Arix Bioscience

Felix BreyerAssociate, Arix Bioscience

David CristinaPrincipal, Arix Bioscience

See all 3 at Arix Bioscience →

Similar investors

Jennifer GriffinPartner, Mission BioCapital

Jeffrey SilversteinPartner, Andreessen Horowitz

Christopher R. ShepardVenture Partner, Apollo Health Ventures

Dimi BarotPartner, Wavemaker Three-Sixty Health

John PrufetaGeneral Partner, Medical Excellence Capital, LLC

Jacob SmithPartner, Cannage Capital

Frequently asked questions

How do I contact Mark Chin?: Mark Chin, Managing Director at Arix Bioscience, can be reached by email. The verified email address is listed on this page.
What is Mark Chin's email address?: Mark Chin's email address uses the arixbioscience.com domain (shown as *****@arixbioscience.com until revealed).
What does Mark Chin invest in?: Mark Chin backs Health tech companies at Series A and Seed, typically writing €92k–€4.6M cheques.
How do I cold email Mark Chin?: Mark Chin backs Health tech companies at Series A and Seed, writing €92k–€4.6M cheques. A concise cold email that leads with relevant traction and one specific ask, sent to the verified address on this page, is the most direct way to reach Mark.
Where is Mark Chin based?: Mark Chin is based in New York City, United States and works at Arix Bioscience.

Every contact is a verified, deliverable email. How Mintround verifies contacts.

Are you Mark Chin? Request removal of this listing.